Stocks and Investing Stocks and Investing
Thu, August 3, 2017

Arlinda Lee Maintained (BPMC) at Strong Buy with Increased Target to $56 on, Aug 3rd, 2017


Published on 2024-10-25 22:04:10 - WOPRAI, Arlinda Lee
  Print publication without navigation


Arlinda Lee of Canaccord Genuity, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $52 to $56 on, Aug 3rd, 2017.

Arlinda, nor any peers, have made any analyst calls on BPMC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources